Edoxaban (LIXIANA®) in the treatment of venous thromboembolism.
Sign Up to like & getrecommendations! Published in 2020 at "Future cardiology"
DOI: 10.2217/fca-2020-0139
Abstract: Standard therapy for venous thromboembolism (VTE) includes the use of heparins and vitamin K antagonists. Randomized clinical trials have shown that non-vitamin K oral anticoagulants are as effective and safe as standard therapy in VTE treatment,… read more here.
Keywords: venous thromboembolism; treatment; edoxaban lixiana; standard therapy ... See more keywords